한국어
English
日本語
中文(简体)
Lyrica Tablets (Riluzole)
50mg
Tablet · Prescription medication
Sanofi-Aventis Korea Co., Ltd.
Riluzole is a central nervous system medication that slows the progression of amyotrophic lateral sclerosis.
MFDS ingredient code M093987
Riluzole is a drug that acts on the central nervous system, primarily used for the treatment of amyotrophic lateral sclerosis. This ingredient is prescribed with the purpose of reducing neuronal damage and slowing the progression of the disease. It belongs to a class of medications that help maintain nervous system function.
Riluzole inhibits the excessive release of the neurotransmitter glutamate from nerve cells. This reduces neuronal hyperexcitability and damage, thereby delaying muscle weakness and deterioration of nerve function. As a result, it has the effect of decreasing the rate of disease progression.
Approved uses differ by product. Check each product's information for its actual use.
Unlike other central nervous system medications, riluzole is specialized in glutamate regulation. This leads to a pronounced neuroprotective effect in amyotrophic lateral sclerosis. Its focus on inhibiting neuronal damage, compared to similar drugs, is a notable characteristic.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.
